ACTIVE SUBSTANCE / INN

EXENATIDE SYNTHETIC

Brand name(s): BYDUREON BCISE, BYDUREON PEN, BYDUREON, EXENATIDE SYNTHETIC, BYETTA
FDA LISTED
PRESCRIPTION
DISCONTINUED
NDA022200
NDA021773
ACTIVE SUBSTANCE
Exenatide Synthetic
REGULATORS
FDA
SPONSORS / MAH
AMYLIN, ASTRAZENECA AB, AMNEAL
TOTAL APPLICATIONS
6
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
BYDUREON BCISENDA209210ASTRAZENECA ABDiscontinued
BYETTANDA021773ASTRAZENECA ABDiscontinued
EXENATIDE SYNTHETICANDA206697AMNEALPrescription
BYETTANDA021919AMYLINPrescription
BYDUREON PENNDA022200ASTRAZENECA ABDiscontinued
BYDUREONNDA022200ASTRAZENECA ABDiscontinued

FULL INTELLIGENCE ON EXENATIDE SYNTHETIC

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →